PHYTOMEDICINES FOR COVID-19: OPPORTUNITIES AND OBSTACLES
International Journal of Pharmaceutical Sciences and Research
; 13(9):3433-3438, 2022.
Article
in English
| EMBASE | ID: covidwho-2033425
ABSTRACT
COVID-19 is a disease caused by SARS-CoV-2 that can trigger respiratory tract infection. Due to its tendency to affect the upper respiratory tract (sinuses, nose and throat) or lower respiratory tract (windpipe and lungs), this disease is life-threatening and affects a large number of populations. This virus's unique and complex nature enhances the scope to look into the direction of herbal plants and their constituents for its prevention and treatment. The herbal remedies can have preventive as well as therapeutic actions. This review focuses on various aspects of using herbal medicines for COVID-19, as herbal constituents may also have adverse effects. Various studies revealed that some medicinal plants show life-threatening adverse effects, so selecting plants, and their related studies should be appropriate and strategic. This article includes various factors that should be considered before herbal drug use in COVID-19 patients. These are clinical trials, safety, molecular mechanism, and self-medication, which have been elaborated. This article also discusses the targets of covid-19 and different coronavirus strains. As before, treatment diagnosis of the disease is very important. Various patents have been filed and granted for its proper diagnosis so that its treatment can be easy.
adult; coronavirus disease 2019; drug safety; drug therapy; herbal medicine; human; lower respiratory tract; lung; medicinal plant; nonhuman; nose; patent; respiratory tract infection; review; self medication; Severe acute respiratory syndrome coronavirus 2; throat; upper respiratory tract; herbaceous agent
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
International Journal of Pharmaceutical Sciences and Research
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS